Characterizing the mechanisms and progression in multiple sclerosis: evidence and new hypotheses for future directions.
作者信息
Crawford Colin L, Hardwicke Peter M D
出版信息
Arch Neurol. 2006 May;63(5):786-7; author reply 787-8. doi: 10.1001/archneur.63.5.786-c.
PMID:16682555
Abstract
摘要
相似文献
1
Characterizing the mechanisms and progression in multiple sclerosis: evidence and new hypotheses for future directions.
Arch Neurol. 2006 May;63(5):786-7; author reply 787-8. doi: 10.1001/archneur.63.5.786-c.
2
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
Arch Neurol. 2005 Sep;62(9):1345-56. doi: 10.1001/archneur.62.9.1345.
3
[Multiple sclerosis. Old observations, new hypotheses, future perspectives].
Medicina (B Aires). 2005;65(2):175-80.
4
Genetics and natural history of multiple sclerosis.
Semin Neurol. 2008 Feb;28(1):7-16. doi: 10.1055/s-2007-1019125.
5
Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2009 May 29;210(1-2):30-9. doi: 10.1016/j.jneuroim.2009.02.010. Epub 2009 Mar 9.
6
What causes multiple sclerosis to worsen?
Arch Neurol. 2007 Feb;64(2):167-8. doi: 10.1001/archneur.64.2.167.
7
Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis.
J Neuroimmunol. 2008 Feb;194(1-2):147-52. doi: 10.1016/j.jneuroim.2007.11.010. Epub 2007 Dec 26.
8
Janus faces of microglia in multiple sclerosis.
Brain Res Rev. 2007 Jun;54(2):274-85. doi: 10.1016/j.brainresrev.2007.03.001. Epub 2007 Mar 12.
9
Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status.
Nat Clin Pract Neurol. 2008 Mar;4(3):159-69. doi: 10.1038/ncpneuro0735. Epub 2008 Jan 29.
10
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
Nat Genet. 2007 Sep;39(9):1108-13. doi: 10.1038/ng2106. Epub 2007 Jul 29.
Zotero 插件